![metal balls and one red ball](https://phgkb.cdc.gov/GAPPKBImage/images/2013-7_cancer.jpg)
What's New
Last Posted: Aug 14, 2020
- Role of POLE and POLD1 in familial cancer
P Mur et al, Genetics in Medicine, August 14, 2020 - Epigenetic Therapies for Cancer
SE Bates. NEJM, August 12, 2020 - Discovery through clinical sequencing in oncology
MTA Donoghue et al, Nat Cancer, August 10, 2020 - Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
Thomas Minta et al. American journal of human genetics 2020 Jul - DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer.
Fiano Valentina et al. Clinical epigenetics 2019 11(1) 152 - Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer
RN Torres et al, JAMA Derm, August 5, 2020 - A DNA Methylation-Based Panel for the Prognosis and Dagnosis of Patients With Breast Cancer and Its Mechanisms.
Liu Xiao-Ping et al. Frontiers in molecular biosciences 2020 7118 - Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Murphy Brittany L et al. Annals of surgical oncology 2020 Jul - Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge H Amarens et al. JAMA oncology 2020 Jul - Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.
Manchanda Ranjit et al. Cancers 2020 Jul 12(7) - Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee Sun-Young et al. BMC cancer 2020 Jul 20(1) 694 - Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan.
et al. ESMO open 2020 Jul 5(4) - Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer.
Niwinska Anna et al. Diagnostics (Basel, Switzerland) 2020 Jul 10(8) - Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis Eloise et al. Journal of general internal medicine 2020 Jul - Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA.
Piombino Claudia et al. Journal of oncology 2020 20206384190
No hay comentarios:
Publicar un comentario